Literature DB >> 28861793

Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Julie A Moreno1, Glenn C Telling2.   

Abstract

Prions represent a new paradigm of protein-mediated information transfer. In the case of mammals, prions are the cause of fatal, transmissible neurodegenerative diseases, sometimes referred to as transmissible spongiform encephalopathies (TSEs), which frequently occur as epidemics. An increasing body of evidence indicates that the canonical mechanism of conformational corruption of cellular prion protein (PrPC) by the pathogenic isoform (PrPSc) that is the basis of prion formation in TSEs is common to a spectrum of proteins associated with various additional human neurodegenerative disorders, including the more common Alzheimer's and Parkinson's diseases. The peerless infectious properties of TSE prions, and the unparalleled tools for their study, therefore enable elucidation of mechanisms of template-mediated conformational propagation that are generally applicable to these related disease states. Many unresolved issues remain including the exact molecular nature of the prion, the detailed cellular and molecular mechanisms of prion propagation, and the means by which prion diseases can be both genetic and infectious. In addition, we know little about the mechanism by which neurons degenerate during prion diseases. Tied to this, the physiological role of the normal form of the prion protein remains unclear and it is uncertain whether or not loss of this function contributes to prion pathogenesis. The factors governing the transmission of prions between species remain unclear, in particular the means by which prion strains and PrP primary structure interact to affect interspecies prion transmission. Despite all these unknowns, advances in our understanding of prions have occurred because of their transmissibility to experimental animals, and the development of transgenic (Tg) mouse models has done much to further our understanding about various aspects of prion biology. In this review, we will focus on advances in our understanding of prion biology that occurred in the past 8 years since our last review of this topic.

Entities:  

Keywords:  Bovine spongiform encephalopathy (BSE); Chronic wasting disease (CWD); Creutzfeldt–Jakob disease (CJD); Prions; Scrapie; Transgenic mice; Transmissible spongiform encephalopathies (TSEs)

Mesh:

Substances:

Year:  2017        PMID: 28861793      PMCID: PMC5902812          DOI: 10.1007/978-1-4939-7244-9_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  188 in total

1.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

Review 2.  Inherited prion diseases and transmission to rodents.

Authors:  J Tateishi; T Kitamoto
Journal:  Brain Pathol       Date:  1995-01       Impact factor: 6.508

3.  Structural clues to prion replication.

Authors:  F E Cohen; K M Pan; Z Huang; M Baldwin; R J Fletterick; S B Prusiner
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

4.  Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE.

Authors:  C Crozet; A Bencsik; F Flamant; S Lezmi; J Samarut; T Baron
Journal:  EMBO Rep       Date:  2001-09-24       Impact factor: 8.807

Review 5.  Detection of cattle-derived BSE prions using transgenic mice overexpressing bovine PrP(C).

Authors:  A Buschmann; E Pfaff; K Reifenberg; H M Müller; M H Groschup
Journal:  Arch Virol Suppl       Date:  2000

6.  Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.

Authors:  Daniel R Pérez; Fred F Damberger; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2010-05-08       Impact factor: 5.469

7.  A novel protective prion protein variant that colocalizes with kuru exposure.

Authors:  Simon Mead; Jerome Whitfield; Mark Poulter; Paresh Shah; James Uphill; Tracy Campbell; Huda Al-Dujaily; Holger Hummerich; Jon Beck; Charles A Mein; Claudio Verzilli; John Whittaker; Michael P Alpers; John Collinge
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

8.  Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.

Authors:  Jenna Crowell; Andrew Hughson; Byron Caughey; Richard A Bessen
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

9.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

10.  Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles.

Authors:  Romolo Nonno; Michele A Di Bari; Franco Cardone; Gabriele Vaccari; Paola Fazzi; Giacomo Dell'Omo; Claudia Cartoni; Loredana Ingrosso; Aileen Boyle; Roberta Galeno; Marco Sbriccoli; Hans-Peter Lipp; Moira Bruce; Maurizio Pocchiari; Umberto Agrimi
Journal:  PLoS Pathog       Date:  2006-02-24       Impact factor: 6.823

View more
  9 in total

Review 1.  Prion disease modelled in Drosophila.

Authors:  Raymond Bujdoso; Andrew Smith; Oliver Fleck; John Spiropoulos; Olivier Andréoletti; Alana M Thackray
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

Review 2.  Prion strains viewed through the lens of cryo-EM.

Authors:  Szymon W Manka; Adam Wenborn; John Collinge; Jonathan D F Wadsworth
Journal:  Cell Tissue Res       Date:  2022-08-27       Impact factor: 4.051

Review 3.  Organoids for modeling prion diseases.

Authors:  Ryan O Walters; Cathryn L Haigh
Journal:  Cell Tissue Res       Date:  2022-01-28       Impact factor: 4.051

4.  Molecular characterisation of atypical BSE prions by mass spectrometry and changes following transmission to sheep and transgenic mouse models.

Authors:  Adriana Gielbert; Jemma K Thorne; Jane M Plater; Leigh Thorne; Peter C Griffiths; Marion M Simmons; Claire A Cassar
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

5.  Co-occurrence of chronic traumatic encephalopathy and prion disease.

Authors:  Satish Kumar Nemani; Silvio Notari; Ignazio Cali; Victor E Alvarez; Diane Kofskey; Mark Cohen; Robert A Stern; Brian Appleby; Joseph Abrams; Lawrence Schonberger; Ann McKee; Pierluigi Gambetti
Journal:  Acta Neuropathol Commun       Date:  2018-12-18       Impact factor: 7.801

6.  Variable Protease-Sensitive Prionopathy Transmission to Bank Voles.

Authors:  Romolo Nonno; Silvio Notari; Michele Angelo Di Bari; Ignazio Cali; Laura Pirisinu; Claudia d'Agostino; Laura Cracco; Diane Kofskey; Ilaria Vanni; Jody Lavrich; Piero Parchi; Umberto Agrimi; Pierluigi Gambetti
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

Review 7.  Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.

Authors:  Jiyan Ma; Jingjing Zhang; Runchuan Yan
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

8.  Unique Structural Features of Mule Deer Prion Protein Provide Insights into Chronic Wasting Disease.

Authors:  Urška Slapšak; Giulia Salzano; Gregor Ilc; Gabriele Giachin; Jifeng Bian; Glenn Telling; Giuseppe Legname; Janez Plavec
Journal:  ACS Omega       Date:  2019-11-15

9.  Adaptive selection of a prion strain conformer corresponding to established North American CWD during propagation of novel emergent Norwegian strains in mice expressing elk or deer prion protein.

Authors:  Jifeng Bian; Sehun Kim; Sarah J Kane; Jenna Crowell; Julianna L Sun; Jeffrey Christiansen; Eri Saijo; Julie A Moreno; James DiLisio; Emily Burnett; Sandra Pritzkow; Damian Gorski; Claudio Soto; Terry J Kreeger; Aru Balachandran; Gordon Mitchell; Michael W Miller; Romolo Nonno; Turid Vikøren; Jørn Våge; Knut Madslien; Linh Tran; Tram Thu Vuong; Sylvie L Benestad; Glenn C Telling
Journal:  PLoS Pathog       Date:  2021-07-26       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.